Jumpertz von Schwartzenberg

Nov 25, 2024 | bmcmedicine.biomedcentral.com | Jumpertz von Schwartzenberg |van Hall |Metabolic Diseases |Heinrich Heine

Young non-obese men without known chronic disease were recruited to participate in a placebo-controlled, randomised, double-blind cross-over study to test the effects of carrageenan intake vs placebo, each over a period of 2 weeks, on insulin sensitivity and metabolism. The trial was performed at the Study Centre of the University Hospital Tübingen, Department of Internal Medicine IV (Endocrinology and Diabetology), Tübingen, Baden-Württemberg, Germany, between October 2015 and December 2016.